**Question:** High dose methotrexate is used for the treatment of(REPEAT)

A. Acute lymphoblastic leukemia
B. Chronic myeloid leukemia
C. Multiple myeloma
D. Non-Hodgkin's lymphoma

**Core Concept:**
Methotrexate is an antifolate drug that inhibits dihydrofolate reductase, an enzyme involved in the synthesis of pyrimidines, purines, and thymidylate. By inhibiting this enzyme, methotrexate interferes with DNA and RNA synthesis, which leads to cell cycle arrest and apoptosis in rapidly dividing cells. High-dose methotrexate is used as part of multi-agent chemotherapy regimens for the treatment of various malignancies, particularly those involving rapidly dividing cells.

**Why the Correct Answer is Right:**
High dose methotrexate is used primarily in the treatment of neoplasms with high proliferative activity, such as:

1. **A: Acute lymphoblastic leukemia** - This type of leukemia involves the rapid proliferation of lymphocytes, making methotrexate an effective agent in the multi-agent chemotherapy regimen.
2. **D: Non-Hodgkin's lymphoma** - Non-Hodgkin's lymphoma is characterized by the uncontrolled proliferation of lymphoid cells, making methotrexate a valuable component of treatment.

**Why Each Wrong Option is Incorrect:**

3. **C: Multiple myeloma** - Multiple myeloma involves the uncontrolled proliferation of plasma cells, and while methotrexate can be used in combination chemotherapy, it is not the primary agent for this disease.
4. **B: Chronic myeloid leukemia** - Chronic myeloid leukemia involves the proliferation of granulocytes and monocytes, not lymphocytes or plasma cells. Methotrexate is not a primary treatment modality for this disease.

**Core Concept:**
High-dose methotrexate is a chemotherapy drug that targets rapidly dividing cells, making it effective in treating malignancies involving lymphocytes, plasma cells, and other rapidly dividing cells.

**Core Concept:**
High dose methotrexate is used in combination chemotherapy for diseases with rapid cell proliferation, such as leukemia and lymphoma, due to its ability to inhibit dihydrofolate reductase and thus, impair DNA synthesis.

**Why Each Wrong Option is Incorrect:**
3. **C: Multiple myeloma** - Multiple myeloma involves the uncontrolled proliferation of plasma cells, and while methotrexate can be used in combination chemotherapy, it is not the primary agent for this disease.
4. **B: Chronic myeloid leukemia** - Chronic myeloid leukemia involves the proliferation of granulocytes and monocytes, not lymphocytes or plasma cells. Methotrexate is not a primary treatment modality for this disease.

**Clinical Pearl:**
High-dose methotrexate is commonly used in combination chemotherapy regimens for lymphomas and leukemias due to its ability to interfere with DNA synthesis. In these conditions, a rapid proliferation of lymphocytes is characteristic, making methotrexate a suitable agent. However, methotrexate is not primarily used in the treatment of